Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00697_DB00730_nanopub.RAeF1j9ugbn7UWPy4rQ7ghy7oxeezmGex5nSbAKroivDo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00697_DB00730 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00697_DB00730 label "DDI between Tizanidine and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Tizanidine by decreasing Tizanidine metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Tizanidine if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00697_DB00730]" assertion.
- drugbank_resource:DB00697_DB00730 identifier "drugbank_resource:DB00697_DB00730" assertion.
- drugbank_resource:DB00697_DB00730 title "DDI between Tizanidine and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Tizanidine by decreasing Tizanidine metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Tizanidine if Thiabendazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00697 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00697_DB00730 assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00697_DB00730 assertion.